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Systemic lupus erythematosus (SLE) patients have increased prevalence of metabolic
syndrome but the underlying mechanisms are unknown. Toll-like receptor 7 (TLR7) that
detects single stranded-RNA plays a key role in antimicrobial host defense and also
contributes to the initiation and progression of SLE both in mice and humans. Here,
we report the implication of TLR7 signaling in high fat diet (HFD)-induced metabolic
syndrome and exacerbation of lupus autoimmunity in TLR8-deficient (TLR8ko) mice,
which develop spontaneous lupus-like disease due to increased TLR7 signaling by
dendritic cells (DCs). The aggravated SLE pathogenesis in HFD-fed TLR8ko mice
was characterized by increased overall immune activation, anti-DNA autoantibody
production, and IgG/IgM glomerular deposition that were coupled with increased kidney
histopathology. Moreover, upon HFD TLR8ko mice developed metabolic abnormalities,
including liver inflammation. In contrast, upon HFD TLR7/8ko mice did not develop SLE
and both TLR7ko and TLR7/8ko mice were fully protected from metabolic abnormalities,
including body weight gain, insulin resistance, and liver inflammation. Interestingly, HFD
led to an increase of TLR7 expression in WT mice, that was coupled with increased
TNF production by DCs, and this phenotype was more profound in TLR8ko mice. Our
study uncovers the implication of TLR7 signaling in the interconnection of SLE and
metabolic abnormalities, indicating that TLR7 might be a novel approach as a tailored
therapy in SLE and metabolic diseases.
Keywords: systemic lupus erythematosus (SLE), toll-like receptor 7 (TLR7), metabolic syndrome, obesity, animal
model, innate immunity, dendritic cells
INTRODUCTION
Epidemiological data provide evidence of a significant increase of autoimmune diseases in the
last 30 years and growing attention has focused on the role of environmental factors, especially
the western dietary habits that have led to the parallel rise in obesity (1). A link between obesity,
metabolic syndrome and autoimmune diseases, including systemic lupus erythematosus (SLE), and
the associated chronic inflammation has been suggested, but the underlying mechanisms are still
unknown (2, 3).
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SLE is a chronic systemic autoimmune disease predominantly
affecting young women, during their reproductive years, and
is characterized by the presence of autoantibodies against self-
nucleic acids and associated proteins (4). Self-nucleic acids
released by dying cells are recognized by the autoantibodies
and form immune complexes, which accumulate in different
organs, leading to increased inflammation and tissue damage.
SLE pathogenesis derives from the combination of genetic,
environmental, hormonal, and epigenetic factors (4). Current
standard of care treatments for SLE are mainly non-selective
immunosuppressants. However, not all patients respond to
these treatments, and one major side effect of the systemic
immunosuppression is the increased incidence of infection (5).
Thus, better understanding of the pathogenesis of SLE is pivotal
for the development of new treatments.
Metabolic syndrome is characterized by several risk factors
that include central obesity, insulin resistance, dyslipidemia,
increased blood pressure, and endothelial dysfunction (6). It is
highly linked to SLE and is associated with cumulative organ
damage (7, 8). Metabolic syndrome is also common in young
patients with recently diagnosed SLE. These patients present
higher levels of inflammatory markers, than SLE subjects without
metabolic syndrome (9). In childhood-onset SLE increased
serum tumor necrosis factor (TNF) levels are associated with
obesity and body fat content (10). The white adipose tissue is a
crucial site for the generation of soluble mediators most of which
carry pro-inflammatory activity. These include classical cytokines
such as tumor necrosis factor alpha (TNF), interleukin 6 (IL-
6), and adipokines such as leptin, adiponectin, and resistin (11).
By their pro-inflammatory action, these molecules contribute
to low-grade inflammation in obese subjects. Dysfunctional
adipose tissue lipid metabolism leads to increased circulating
fatty acids that initiates inflammatory signaling cascades in
the population of infiltrating cells (11). A feedback loop of
pro-inflammatory cytokines exacerbates this pathological state
driving further immune infiltration and cytokine secretion and
disrupts the insulin signaling cascade. In addition to adipose
tissue, other metabolically critical sites, particularly the liver,
are also involved during the course of the disease. Fatty liver
is characterized by excessive triglyceride deposition as lipid
droplets in hepatocytes that trigger mitochondrial oxidative
stress and hepatic inflammation with increased TNF, IL-6, and
IL-1β, cytokine production, which are considered as critical
factors leading to the progression from benign hepatic steatosis
to advanced steatohepatitis or even fibrosis and cirrhosis (12).
All together, these events lead to what is termed a sterile
inflammatory response, which if not appropriately resolved, can
lead to the development of chronic inflammation that underlies
or exacerbates autoimmunity.
Little is known about the early molecular events that lead to
immune cell infiltration and inflammatory cytokine production
in adipose tissue or liver. Nevertheless, the Toll-like receptor
(TLR) family has recently emerged as a critical link between
inflammation and a contributor to obesity and insulin resistance,
Abbreviations: BWF1, (NZB x NZW) F1; DC, dendritic cell; HFD, high fat diet;
pDC, plasmacytoid dendritic cell; SD, standard diet; TLR, Toll-like receptor.
both in mice and in humans (13–15). Among the 10 human TLR
members, TLR2, TLR4, TLR5, and TLR9 have been reported as
regulators of metabolic inflammation and insulin resistance in
liver and adipose tissue (16–19). TLRs are evolutionary conserved
transmembrane receptors that play a critical role in driving
innate and adaptive immunity through the recognition of various
microbial components and the activation of signaling pathways
critical for the induction of inflammatory responses (20). In
addition to sensing exogenousmicrobial ligands, TLRs also detect
endogenous molecules released from damaged tissues or dead
cells and regulate many sterile inflammatory processes (21).
Mammalian endosomal TLRs (TLR3, TLR7, TLR8, and TLR9)
and especially TLR7 play an important role in the development
of SLE both in humans (22–24) and in mice (25–28). TLR7
and TLR8 are phylogenetically similar and both sense single
stranded RNA (ssRNA) in humans, while in the mouse only
TLR7 senses ssRNA (29–31). Despite the fact that murine
TLR8 does not seem to have a ligand (32, 33), we previously
demonstrated that it plays an important biological role by
controlling TLR7-mediated lupus. Indeed, TLR8-deficiency in
mice on the C57BL/6 background leads to lupus development
due to increased TLR7 expression and signaling by DCs (26–28).
Hence, tight control and regulation of TLR7 is pivotal for
avoiding SLE and inflammatory pathology.
The implication of TLR7 in the chronic inflammation of
SLE in the context of obesity or metabolic syndrome has never
been reported to date. Given the increased risk of metabolic
syndrome in SLE patients and the fact that TLR7 is implicated
in SLE development we hypothesized that TLR7 might be the
connecting link between metabolic syndrome and SLE. Thus,
in the current study we evaluated the impact of high fat diet
(HFD) on the development of SLE and metabolic syndrome
in TLR8-deficient mice (TLR8ko) that spontaneously develop
SLE due to increased TLR7 signaling by DCs (26–28). Our data
revealed that in TLR8ko mice HFD exacerbated the development
of SLE, and increased the occurrence of metabolic abnormalities.
The elevated disease course in HFD-fed TLR8ko mice was
accompanied by increased TLR7 expression and signaling in
DCs. In contrast to TLR8ko mice, TLR7/8ko mice were fully
protected from SLE and metabolic syndrome. Hence, TLR7
signaling is implicated in the connection between SLE and
metabolic disease.
MATERIALS AND METHODS
Mice
TLR7ko, TLR8ko, and double TLR7/8ko mice were generated as
described previously (26, 31, 34). All three TLR-deficient mouse
lines were backcrossed on the C57BL/6 background for more
than 10 generations. Familiar transmission shapes the distinct
intestinal microbiota of TLR-deficient mice (35). Therefore, in
order to normalize the microbiota between the TLR-deficient
mice and WT controls and because the TLR7 and TLR8 genes
are both located in the X chromosome, female age-matched
TLR-deficient mice and their respective WT control mice were
derived by mating littermate TLR-heterozygous female mice with
WT or TLR-deficient male mice (e.g., TLR8X+X− x TLR8X+Y,
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or TLR8X−Y). Mice were allowed to consume water and pellet
shew ad libitum. For the HFD-induced obesity model, mice
received either HFD (Research Diets, D12492; 60% of kcals
from fat and 20% of kcals from carbohydrate) or standard diet
(SD) (Research Diets, D12450J; 10% of kcals from fat, 70% of
kcals from carbohydrate) beginning at 3 months of age. Mice
were housed under specific pathogen-free conditions at the
Center d’Immunologie de Marseille-Luminy and experiments
were conducted in accordance with institutional guidelines for
animal care and with protocols approved by the Comité National
de Réflexion Ethique sur l’Expérimentation Animale (protocol
number 13.325).
Reagents
R848, LPS from E. coli 0111-B4, CpG ODN 1826 and poly I:C
were purchased from Invivogen.
RNA Isolation and Q-PCR
Total RNA was isolated with TRIzol reagent (Ambion, Life
Technologies). RNA was reversed transcribed with Superscript II
reverse transcriptase (Invitrogen) and Q-PCR for TLR7, TNF, IL-
6, IL-1β, IL-10, Foxp3, and β-actin was performed as described
previously (26). Primers are listed in Table S1.
Serological Analysis
Evaluation of IgM, and IgG autoantibodies against DNA
and RNA on serum samples were performed as described
previously (26).
Glucose Tolerance Test
Mice fed HFD or SD were injected intraperitonially with D-
glucose (1 g/kg body weight) after 6 h fast. Blood was collected
from tail tip at the indicated time points and glycemia was
determined using a glucometer (ACCU-CHEK, Roche).
Flow Cytometric Analysis
Mice were euthanized, perfused with 10ml sterile PBS solution
to remove blood cells and then spleen, liver, or adipose tissue
were extracted. Spleen was passed through a 200-gauge nylon
mesh to obtain a single cell suspension followed by erythrocyte
lysis. Splenocytes were digested with digestion solution (RPMI
medium containing 2% FCS, 7mg/ml Collagenase II and 1mg/ml
DNase I) for 20min at 37
◦
C. Following enzymatic digestion,
cell suspension was passed through a 70µm cell strainer and
splenocytes were collected by centrifugation. Isolation of hepatic
lymphocytes with mechanical dissection was carried out as
follows: liver was cut in small pieces by scissors, suspended in
digestion solution, incubated at 37
◦
C for 20min, cell suspension
was passed through a 100µm cell strainer, centrifuged, and
erythrocytes were lysed. After centrifugation the cell pellet was
resuspend in 80% Percoll solution, overlaid by a layer of 40%
Percoll solution followed by centrifugation at 1,500 g for 20min,
the cells were aspirated from the Percoll interface and harvested
by centrifugation. Stromal vascular fraction cells from adipose
tissue were isolated with an adipose tissue dissociation kit from
Miltenyi Biotec using manufacturer’s instructions.
Cell suspensions were incubated with 24G2 hybridoma
supernatant and then stained using fluorochrome-labeled
antibodies against the following antigens: CD45.2, B220, CD3,
NK1.1, CD11b, Ly6G, CD44, CD62L, CD38, CD138, GL7
from BD Biosciences, F4/80, CD4, CD8, IA/IE (MHC class
II) from eBioscience and CD11c, CD64, SiglecH, CD69 from
Biolegend. For intracellular staining of TLR7 and TNF, cells
were fixed with Cytofix (BD Biosciences), permeabilized with
0.1% saponin containing staining buffer and stained in saponin
buffer using immunofluorescence labeled antibodies for TLR7
(A94B10 from BD Biosciences) and TNF (MP6-XT22 from BD
Biosciences). For intracellular staining of Foxp3, cells were fixed,
permeabilized and stained with a Foxp3 staining kit, according to
themanufacturer’s instructions (FJK-16s from eBioscience). Flow
cytometry was conducted using an LSR2 (BD Biosciences) and
data were analyzed with FlowJo (Tree Star). The gating strategies
for the various cell populations are presented in Figures S1, S2.
Histology and Immunofluorescence
For histopathology studies, livers were fixed in formalin and
embedded in paraffin. For light microscopy 3–4µm thick tissue
sections were stained with hematoxylin and eosin (H&E). To
determine the extent of renal and liver damage, biopsies were
analyzed by a pathologist. Typical glomerular active lesions of
lupus nephritis were evaluated based on glomerular cellularity,
glomerular deposits, and interstitial inflammation. At least
20 glomeruli per kidney were evaluated. Kidney scoring was
from 0 to 4 corresponding to no, low, moderate, high and
severe changes, respectively. Liver scoring was from 0 to 3
[0, no inflammation; 1, mild inflammation (<5% of section
area); 2 moderate inflammation (5–10% of section area); and
3 marked inflammation (more than 10% of section area)]. For
cryostat sections, livers, and kidneys were embedded in OCT-
compound and frozen in liquid nitrogen. Sections were cut on
a cryostat at 10µm, thaw-mounted on gelatinized slides, and
immunofluorescence IgG and IgM staining on kidney sections
and Oil red O staining on liver sections were performed as
described previously (26, 36).
Statistical Analysis
Statistics were done using Prism 7 (GraphPad Software). In
Figures 1A,B, 3G comparisons were done only between two
groups (SD-fed WT vs. TLR8ko mice, or HFD-fed WT vs.
TLR8ko mice) and the statistics were done using Wilcoxon rank
sum test. Statistics in Figures 1C–F, 2, 3A–F, 4, 5, 6A,B were
done by Kruskal-Wallis test followed byWilcoxon rank sum tests
and correction for multiple comparisons using the Benjamini-
Hochberg method. P-values indicated throughout correspond to:
p < 0.05 (∗), p < 0.01 (∗∗), p < 0.001 (∗∗∗), p < 0.0001 (∗∗∗∗).
RESULTS
HFD Aggravates the Lupus Phenotype of
TLR8ko Mice
TLR8ko mice on the C57BL/6 background develop lupus due
to increased TLR7 expression by DCs (26, 28). To evaluate the
effect of high fat diet (HFD) on TLR7-dependent lupus, 3 months
old female TLR8ko mice and their respective WT controls (see
materials and methods) were fed on either standard diet (SD)
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FIGURE 1 | Body weight gain over time of (A) TLR8ko or (B) TLR7/8ko mice and their respective WT control mice fed a standard diet (SD) or a high fat diet (HFD).
Spleen weight of 8 months old female (C) TLR8ko or (D) TLR7/8ko mice and their WT controls fed-SD or -HFD. Representative flow cytometry plots (left) and
(Continued)
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FIGURE 1 | graphical analysis (middle and right) of B220+GL7+CD38− GC B cells in splenocytes derived from 8 months old female (E) TLR8ko or (F) TLR7/8ko
mice and their WT controls fed-SD or -HFD. In (C,D) and the right in (E,F), each point represents the value obtained from one mouse and horizontal bars denote
mean value. In (A–D) data are representative of 2 and 4 independent experiments for SD and HFD, respectively. In (E,F) data are representative of 2 independent
experiments for each type of diet.
or HFD for a total period of 5 months. Total body weight mass
was measured weekly after SD or HFD was initiated. HFD-fed
mice gainedmore weight than SD-fed mice, but body weight gain
was similar between TLR8ko and WT control mice (Figure 1A).
In parallel, we also evaluated the body weight gain of TLR7/8ko
and TLR7ko mice vs. their WT controls. Although, upon SD
TLR7/8ko mice gained similar weight as their WT controls
(Figure 1B), interestingly HFD-fed TLR7/8ko or TLR7ko mice
showed reduced weight gain compared to their WT controls
(Figure 1B, Figure S3A). The reduced weight gain was not due
to differences in food consumption between the genotypes since
the assessment of food intake of SD- and HFD-fed TLR8ko,
TLR7/8ko, and their WT controls was similar (data not shown).
Evaluation of liver, ovarian/uterus, and inguinal white adipose
tissue weight, revealed increased fat accumulation in HFD-
fed vs. SD-fed mice, but with no evident differences between
TLR8ko and WT mice (Figures S4A,B, Table S2), while HFD-
fed TLR7/8ko mice had reduced inguinal fat weight than their
WT controls (Figures S4C,D, Table S3). These data suggest that
upon HFD feeding TLR7-deficiency protects female mice from
excess weight gain.
Since TLR8-deficiency in mice spontaneously leads to lupus
that is accompanied by splenomegaly and altered splenic immune
cell populations (26, 28), we next evaluated these parameters
in the context of HFD. SD-fed TLR8ko mice developed
splenomegaly compared to SD-fed WT controls, which is
in accordance with our previous studies (26, 28), and this
phenotype became even more profound in HFD-fed TLR8ko
compared to SD-fed TLR8ko mice (Figure 1C, Table S4). On
the contrary, SD- and HFD-fed TLR7/8ko and HFD-fed TLR7ko
mice had normal spleen weight compared to their WT controls
(Figure 1D, Table S5, Figure S3B). Thus, HFD exacerbates
splenomegaly in TLR8ko mice and this phenotype is TLR7-
dependent since it is abrogated in TLR7/8ko mice.
Flow cytometric analysis of the major immune splenic cell
populations (cDCs, pDCs, CD11c+ cells, NK, NKT, neutrophils,
plasmablasts, B and T cells) revealed no major differences
between SD-fed TLR8ko and WT mice (Table S4), except of
increased percentages of germinal center (GC) B cells and
CD11c+ cells in TLR8ko mice (Figure 1E, Table S4), which
is in agreement with our previous reports (26, 28). On the
contrary, in SD-fed TLR7/8ko mice GC B cells were decreased
while the percentages of CD11c+ cells were normal, compared
to their WT controls (Figure 1F, Table S5). HFD led to an
increase of the total numbers of GC B cells in TLR8ko mice,
but not in their WT controls (Figure 1E), while in HFD-fed
TLR7/8ko or TLR7ko mice this population was similar to WT
mice (Figure 1F, Figure S3C). Moreover, the percentages of
cDCs were increased in HFD-fed TLR8ko mice, while HFD-fed
TLR7/8ko mice had normal percentages (Tables S4, S5). Finally,
HFD led to a dramatic reduction of CD8+ T cells in TLR8ko,
but not in TLR7/8ko mice (Tables S4, S5). Thus, HFD leads to a
TLR7-dependent increase of cDCs and reduction of CD8+ T cells
in TLR8ko mice.
Next, we assessed serum levels of IgG autoantibodies against
DNA and RNA, as well as IgM and found increased levels in
SD-fed TLR8ko vs. WT mice (Figure 2A). Interestingly, HFD
led to an increase of anti-DNA antibodies in HFD-fed TLR8ko
vs. SD-fed TLR8ko mice, but that was not the case for anti-
RNA antibodies or IgM levels (Figure 2A). In contrast, SD- or
HFD-fed TLR7/8ko mice had reduced levels of IgM and IgG
autoantibodies against DNA and RNA compared to their WT
controls (Figure 2B). These results are in agreement with the
differences that we observed in GC B cells in the three genotypes
(Figures 1E,F) and strongly suggest that TLR7 is pivotal for
autoantibody production.
For renal pathology evaluation, histopathological scoring
of glomerular, and interstitial nephritis was performed. HFD-
fed TLR8ko mice had increased total kidney and glomerulus
score compared to SD-fed TLR8ko or HFD-fed WT mice,
while HFD-fed TLR7/8ko mice did not develop any kidney
pathology (Figures 2C,D, Figure S5, Table S6). Furthermore,
we observed increased IgG and IgM glomerular deposition in
HFD-fed TLR8ko mice vs. SD-fed TLR8ko or HFD-fed WT
mice (Figure 2C). In contrast, HFD-fed TLR7/8ko and TLR7ko
mice showed dramatically diminished glomerular deposition
of IgM and IgG compared to HFD-fed WT mice (Figure 2D,
Figure S3D). Taken together, these results demonstrate that HFD
worsens anti-DNA autoantibody production and glomerular IgM
and IgG immunodeposits in TLR8 deficient mice, and that both
phenomena depend on TLR7 signaling.
HFD Exacerbates Liver Inflammation in
TLR8ko Mice
Subclinical liver disease is common in SLE (37, 38), thus, in
order to determine the effect of HFD and TLR7 expression
on liver disease, histopathological evaluation was performed
on hematoxylin/eosin and Oil Red O stained liver sections.
HFD-fed TLR8ko mice showed an increased average hepatic
inflammation with multifocal centrolobular and periportal
lymphocytic infiltrates compared to SD-fed TLR8ko and HFD-
fed WT mice (Figure 3A, Figure S5, Table S6). Interestingly,
HFD-fed TLR7/8ko mice did not develop hepatic inflammation
(Figure 3B, Figure S5, Table S6). Moreover, HFD led to a similar
increase of the hepatic lipid content, in both TLR8ko and
WT mice (Figure 3C), while in HFD-fed TLR7/8ko mice the
hepatic lipid content was similar to WT controls (Figure 3D).
The increased hepatic inflammation in HFD-fed TLR8ko mice
was coupled with increased hepatic mRNA expression of the
pro-inflammatory cytokines TNF and IL-6 compared to HFD-
fed WT or SD-fed TLR8ko mice (Figure 3E). In contrast, both
SD- and HFD-fed TLR7/8ko mice had similar hepatic TNF, IL-
6 and IL-1β mRNA levels to their WT controls (Figure 3E).
Evaluation by FACS analysis of the major hepatic immune cell
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FIGURE 2 | Effect of HFD on serum levels of anti-DNA and anti-RNA autoantibodies and kidney pathology in TLR8ko, TLR7/8ko, and WT mice. Levels of anti-DNA
and anti-RNA autoantibodies and IgM in sera of 8 months old female (A) TLR8ko or (B) TLR7/8ko mice and their WT controls upon SD or HFD were evaluated by
(Continued)
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FIGURE 2 | ELISA. Each point represents the value of one mouse and horizontal bars denote mean. In (A) data are pooled from two independent experiments.
Kidney sections from female 8 months old (C) SD or HFD-fed TLR8ko and WT or (D) HFD-fed TLR7/8ko and WT mice (n = 6, for each genotype) were stained with
H&E, anti-IgM, or anti-IgG antibodies. In (A,B) data are representative of 2 and 4 independent experiments for SD and HFD, respectively. In (C,D) data are
representative of 2 independent experiments for each type of diet.
populations revealed that HFD-fed TLR8ko mice had increased
numbers of CD11c+ cells and hepatic macrophages (defined
as CD45.2+MHCII+CD11b+F4/80+CD64+) compared toHFD-
fed WT mice (Table S2, Figure 3F), while in HFD-fed TLR7/8ko
mice the numbers of CD11c+ cells and hepaticmacrophages were
normal (Table S3, Figure 3F). Evaluation of the activation status
of the hepatic macrophages by the expression of CD11c or CD86
did not reveal obvious differences among the three genotypes
(data not shown). Therefore, these data demonstrate that HFD
consumption leads to a TLR7-dependent hepatic inflammation
in lupic TLR8ko mice.
Since liver maintains glucose metabolism, we performed
glucose tolerance test (GTT) in SD- and HFD-fed mice.
TLR8ko and WT mice showed similar glucose kinetics
(Figure 3G), while HFD-fed TLR7/8ko and TLR7ko
mice showed improved glucose tolerance compared to
their HFD-fed WT controls (Figure 3G, Figure S3E),
suggesting that TLR7-deficiency protects from HFD-induced
glucose intolerance.
Increased T Cell Activation and Foxp3+
Regulatory T Cells in TLR8ko Mice
Since autoreactive CD4+ T cells play an essential role in SLE and
steatohepatitis, we next evaluated the percentages/numbers and
status of splenic and hepatic T cells. HFD led to a reduction of
splenic CD4+ and CD8+ T cells both in WT and TLR8ko mice
compared to SD-fed mice (Table S4), while no differences were
observed between SD- and HFD-fed TLR7/8ko mice (Table S5).
The percentages of splenic effector memory (CD44hiCD62L−)
CD4+ and CD8+ T cells were increased in SD- and HFD-
fed TLR8ko vs. WT controls (Figure 4A). On the contrary, the
percentages of splenic effector memory CD4+ and CD8+ T
cells were normal in SD-fed TLR7/8ko, whereas HFD induced
an increase in WT but not in TLR7/8ko mice (Figure 4B).
Accordingly, splenic naïve (CD44−CD62L+) CD4+ and CD8+ T
cells were reduced in SD-fed TLR8ko vs. WTmice, whereas HFD
led to an important reduction of these cell populations in both
genotypes (Figure 4A). In contrast, in SD-fed TLR7/8ko mice,
the percentages of splenic naïve CD4+ and CD8+ T cells were
similar to WTmice, while HFD led to a reduction inWT, but not
in TLR7/8ko mice (Figure 4B).
In the liver, the percentages of effector memory CD4+ T
cells were similar between TLR8ko, TLR7/8ko and WT mice
(Figure 4C). On the contrary, hepatic effector memory CD8+
T cells were increased both in SD- and HFD-fed TLR8ko mice
compared to theirWT controls (Figure 4C). In SD-fed TLR7/8ko
mice hepatic effector memory CD8+ T cells were similar to WT
controls, whereas HFD led to an increase of effector memory
CD8+ T cells in WT, but not in TLR7/8ko mice (Figure 4D).
Respectively, hepatic naïve CD8+ T cells percentages were
normal in SD-fed TLR7/8ko mice, while HFD induced a strong
decrease in their WT controls, but not in HFD-fed TLR7/8ko
mice (Figure 4D). Altogether, these data show that both in the
spleen and liver HFD leads to an increase of effector memory
and decrease of naïve CD4+ and CD8+ T cells in a TLR7-
dependent manner.
CD4+ forkhead box protein 3 (Foxp3)+ regulatory T
(Treg) cells maintain self-tolerance by suppressing autoreactive
lymphocytes and are critical regulators of cellular metabolism
and glucose homeostasis (39, 40). Considering that defects in
Treg cells can contribute in SLE pathogenesis and steatohepatitis
(41), we next evaluated splenic and hepatic Treg cells. SD- and
HFD-fed TLR8ko mice had increased percentages of Treg cells
compared to WT controls, both in the spleen (Figure 5A) and
the liver (Figure 5E). The total number of splenic and hepatic
Treg cells were similar in TLR8ko and WT mice upon SD
(Figures 5A,E), while HFD led to a decrease of hepatic Treg
cells in WT mice, but not in TLR8ko mice (Figure 5E). In
contrast, TLR7/8ko mice had similar percentages and numbers
of splenic and hepatic Treg cells to their WT controls, both
upon SD or HFD (Figures 5B,F). In addition, both splenic
and hepatic Treg cells where more activated in SD- and HFD-
fed TLR8ko mice vs. WT controls (Figures 5C,G). In marked
contrast, splenic and hepatic Treg cells of TLR7/8ko mice
showed similar activation status to WT cells (Figures 5D,H).
No substantial differences were observed regarding splenic or
hepatic Foxp3 mRNA between TLR8ko, TLR7/8ko, TLR7ko,
and their WT controls (Figures 5I,J, Figure S3F). Given that
Treg-mediated suppression can be directly linked to IL-10
production (42), we next assessed splenic and hepatic expression
of IL-10. We observed a 2-fold and 5-fold increase of IL-10
mRNA levels in the spleen and liver, respectively, of HFD-
fed TLR8ko mice vs. WT controls (Figures 5I,J), while IL-10
levels were normal in TLR7/8ko and TLR7ko mice (Figures 5I,J,
Figure S3G). Altogether these results indicate that splenic and
hepatic Treg cells are increased in TLR8ko vs. WT mice, and
upon HFD this increase is accompanied by elevated levels
of the anti-inflammatory cytokine IL-10. Importantly, these
phenomena are TLR7-dependent since they are abolished in
TLR7/8ko mice.
HFD Induces a Profound Increase of
TLR7+TNF+ DCs in TLR8ko DCs
To further determine whether exacerbated lupus and metabolic
abnormalities observed in HFD- vs. SD-fed TLR8ko mice could
be attributed to augmented TLR7 signaling, we next evaluated
TLR7 expression levels. While HFD did not have an effect
on splenic TLR7 mRNA expression (Figure 6A), it strongly
increased of hepatic TLR7 mRNA levels in TLR8ko vs. WT
mice (Figure 6B). In contrast, and as expected TLR7 mRNA was
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FIGURE 3 | Exacerbation of liver inflammation upon HFD is more profound in TLR8ko vs. WT mice, while TLR7/8ko mice are protected. Liver sections from
8-months-old SD- or HFD-fed TLR8ko or TLR7/8ko mice and their WT controls (n = 6 for each genotype) were stained with (A,B) H/E or (C,D) oil-red O. Data are
(Continued)
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FIGURE 3 | representative of 2 to 3 independent experiments. (E) Expression of TNF, IL-6, and IL-1β mRNA levels was evaluated in the liver of SD- or HFD-fed
TLR8ko, TLR7/8ko, or WT mice by Q-PCR. Plots represent mean ± SD of triplicates, with n = 4–6 mice combined per genotype. Data are representative of 2
independent experiments. (F) Frequency and total numbers of hepatic macrophages (defined as CD45.2+MHCII+CD11b+F4/80+CD64+) from SD- or HFD-fed
TLR8ko, TLR7/8ko, or WT mice were evaluated by FACS analysis. Data are representative of 2 independent experiments. (G) Glucose tolerance test (GTT) of
7-months-old SD- or HFD-fed TLR8ko or TLR7/8ko mice and their WT controls. Data are representative of 2–3 independent experiments.
undetectable in TLR7/8ko mice (Figures 6A,B). Furthermore,
we evaluated TLR7 protein levels by FACS analysis in pDCs,
cDCs and macrophages derived from the spleen, liver, and
adipose tissue of TLR8ko and WT mice. Upon SD, TLR8ko mice
showed higher TLR7 protein levels than WT mice in pDCs,
cDCs, and macrophages in all three tissues (Figures 6C,D).
Compared to SD-fed mice, HFD led to an increase of TLR7
expression in pDCs and cDCs in both genotypes, but again
the HFD-TLR8ko-derived cells had higher TLR7 expression
than HFD-WT cells in all three tissues (Figures 6C,D). In
contrast, HFD did not affect TLR7 expression in macrophages
(Figures 6C,D).
Next, in order to evaluate if the increased TLR7 expression
resulted in altered cytokine production, we measured TNF and
type I IFN protein levels by flow cytometry. The expression
of type I IFN was quite low (data not shown) and difficult to
interpret, thus we focused our analysis on TNF production by
TLR7 expressing cells. Compared to SD-fed mice, HFD led to
an increase of TNF expression mainly in TLR7+ pDCs and
cDCs derived from the spleen and liver, but not the inguinal
fat (Figure 6D). Interestingly, SD-fed TLR8ko mice showed
higher TNF expression in TLR7+ pDCs and cDCs than SD-fed
WT cells, and this difference become even more profound in
HFD-fed mice (Figure 6D). However, in macrophages HFD did
not increase TNF expression in TLR7+ cells either in WT or
in TLR8ko mice (Figure 6D). These results are in accordance
with our previous findings that TLR8-deficiency in mice leads
to increased TLR7 expression and signaling in DCs, but not
in macrophages (26, 28). Overall, TLR8ko pDCs and cDCs
have higher TLR7 expression than WT cells, whereas HFD-
mediated obesity leads to an increase of TLR7+TNF+ pDCs
and cDCs, and this is more profound in TLR8ko than in
WT mice.
DISCUSSION
SLE patients have an increased prevalence of metabolic
syndrome and this chronic inflammation seems to be
associated with cumulative organ damage (7, 8). Mounting
evidence suggest an important contribution of TLR7
signaling in lupus disease development both in mice (25–
28, 43) and humans (44–47). However, its respective
contribution to the metabolic abnormalities observed in
the SLE setting is unknown. Using TLR8ko mice on the
C57BL/6 background that develop lupus due to increased
TLR7 expression and signaling by dendritic cells (26, 28),
our data clearly demonstrate that HFD leads to exacerbation
of lupus autoimmunity and metabolic parameters and these
phenomena could be attributed to increased TLR7 expression
and signaling (Figure 7).
Obesity leads to a breakdown of the body’s protective self-
tolerance, creating the optimal environment for autoimmune
diseases, and generates a pro-inflammatory environment likely
to worsen disease progression (3). Here, we demonstrated that
HFD-induced obesity aggravated the severity of lupus in TLR8ko
female mice. This was characterized by profound splenomegaly,
kidney IgG and IgM immune-deposits, increased percentages
and numbers of GC B cells, anti-DNA serum levels and liver
inflammation. B cell-intrinsic TLR7 signaling is essential for the
development of germinal centers (48). Indeed, in TLR7/8ko mice
the percentages of GC B cells were decreased, while in HFD-fed
TLR8ko mice both the percentages and numbers of GC B cells
were increased and could explain the increased levels of anti-
DNA autoantibodies in HFD-fed TLR8ko mice. Moreover, in
accordance with our results previous studies in the female (NZB
x NZW) F1 (BWF1) mouse model of SLE have shown that high
dietary fat accelerates lupus nephritis and leads to shorter life
span (49–51). In HFD-fed TLR8ko mice we did not observe any
lethality up to 12 months of age (data not shown), since TLR8ko
mice develop a rather mild lupus phenotype compared to BWF1
mice. Indeed, upon SD and up to 12 months TLR8ko mice have
normal levels of proteinuria and a 100% survival rate (28), while
by the age of 10 months 50% of BWF1 mice develop pathogenic
levels of proteinuria and die (51). HFD-fed TLR8ko andWTmice
exhibited similar accelerated weight gain, which was coupled with
increased inguinal and ovarian fat weight compared to SD-fed
control mice. However, female HFD-fed TLR7/8ko and TLR7ko
mice showed reduced weight gain and had reduced inguinal fat
weight compared to HFD-fed WT controls. This is in agreement
with a previous study where upon HFD male TLR7ko mice
had normal body weight, but reduced adipose fat pad weight
compared to littermateWTmice (52). Strikingly, TLR7/8ko mice
did not show any sign of lupus autoimmunity. Thus, TLR7
signaling contributes to the exacerbation of lupus autoimmunity
in HFD-fed TLR8ko mice, as well as to the accelerated weight
gain that was observed in HFD-fed WT vs. TLR7-deficient mice.
Importantly, our study indicates that TLR8ko females provide an
ideal mouse model to study the long-term effect of HFD-induced
low grade-inflammation in the setting of SLE since mice have a
100% survival rate up to 12 months.
Despite the high heterogeneity in the literature regarding
the prevalence of SLE-associated liver diseases, it is becoming
apparent that liver is an important target of SLE (53). Subclinical
liver disease is common in SLE, where 25–50% of patients with
lupus develop abnormal liver function at some point (37, 38). We
found that TLR8ko mice developed a TLR7-dependent hepatic
inflammation that was accompanied by increased production
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FIGURE 4 | TLR7-dependent increase of effector memory CD4+ and CD8+ T cells in TLR8ko mice. Representative flow cytometry plots (upper) and graphical
analysis (lower) of (A,B) splenocytes and (C,D) hepatocytes from 8 months old SD- or HFD-fed TLR8ko or TLR7/8ko mice and their WT controls, analyzed for the
expression of CD3, CD4, CD8, CD44, and CD62L. CD44/CD62L relative expression were used to identify naive (CD44lo/−CD62Lhi), central memory
(CD44hiCD62Lhi), and effector memory (CD44hiCD62Llo) subpopulations. Plots represent mean ± SD. Data are representative of 2 and 3 independent experiments
for SD and HFD, respectively.
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FIGURE 5 | Increased numbers and activation of Treg cells in HFD-fed TLR8ko mice are TLR7-dependent. Total (A–D) splenocytes and (E–H) hepatic lymphocytes
were isolated from 8 months old TLR8ko (SD, n = 5; HFD, n = 4) and WT (SD, n = 4; HFD, n = 6) or TLR7/8ko (SD, n = 4; HFD, n = 7) and WT (SD, n = 4; HFD, n =
6) mice and analyzed by flow cytometry for (A,B,E,F) Treg cells (CD4+Foxp3+) and (C,D,G,H) their activation status (CD44+CD69+). Expression of Foxp3 and IL-10
mRNA levels were evaluated in the (I) spleen and (J) liver of SD- or HFD-fed TLR8ko, TLR7/8ko, or WT mice by Q-PCR in triplicates. Plots in (I–J) represent mean ±
SD of triplicates, with n = 4–6 mice combined per genotype. Data in (A–H) and (I,J) are representative of 3 and 2 independent experiments, respectively.
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FIGURE 6 | HFD-induced obesity promotes TLR7 and TNF expression by pDCs and cDCs. Total RNA was extracted from (A) spleen and (B) liver of SD- or HFD-fed
WT, TLR8ko, and TLR7/8ko mice and the expression of TLR7 was assessed by Q-PCR. Plots represent mean ± SD of triplicates, with n = 4–6 mice combined per
(Continued)
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FIGURE 6 | genotype. FACS plots represent (C) TLR7 expression and (D) TLR7 vs. TNF expression on pDCs (CD45.2+CD11cintSiglecH+), cDCs
(CD45.2+CD11c+MHCIIhiDC64−), and macrophages (MFs) (CD45.2+CD64+CD11c+CD11b+) derived from the spleen, liver, or inguinal adipose tissue of 8
months-old SD- or HFD-fed female WT and TLR8ko mice (n = 3 per genotype). In panel (D) gates have been placed relative to isotypes controls as shown
in Figure S1. Data in (A,B) and (C,D) are representative of 2 and 3 independent experiments, respectively.
FIGURE 7 | Graphical abstract of how increased TLR7 signaling by DCs can lead to lupus and metabolic syndrome. Under standart diet (SD), TLR8ko mice develop
spontaneous SLE due to increased TLR7 expression and signaling by DCs. High fat diet (HFD) leads to the development of MS in WT mice, and exacerbated SLE,
and MS in TLR8ko mice, due to increased TLR7 signaling, compared to SD-fed mice. Deletion of TLR7 (TLR7/8ko mice) protects TLR8ko mice from HFD-induced
exacerbation of SLE and MS development. DCs, dendritic cells; MS, metabolic syndrome; SLE, systemic lupus erythematosus; ssRNA, single stranded RNA; TLR7,
Toll-like receptor 7.
of pro-inflammatory cytokines (TNF and IL-6), as well as
lymphocytic and macrophage infiltrates. Moreover, HFD led
to the worsening of the hepatic inflammation in TLR8ko
mice. In accordance to our findings regarding the involvement
of TLR7 signaling in hepatic inflammation, transgenic mice
that overexpress TLR7 develop SLE and massive hepatic
inflammation (54), while the contribution of TLR7 signaling in
alcoholic hepatic inflammation both in mice and in humans
has also been reported recently (55). Therefore, TLR7 signaling
contributes to SLE-associated liver diseases.
Treg cells are a subset of CD4+ T cells that maintain self-
tolerance by suppressing autoreactive lymphocytes. Defects in
Treg cells are therefore thought to contribute to SLE pathogenesis
(41). Indeed, scurfy mice that are deficient in Treg cells
develop generalized autoimmune disorder, including SLE (56).
Nevertheless, the data regarding the numbers and function of
Treg cells especially in human SLE are contradictory (41). The
percentages and numbers of hepatic Treg cells and the activation
status of splenic and hepatic Treg cells were increased in TLR8ko
mice. These observations correlated with higher hepatic levels of
IL-10 in HFD-fed TLR8ko than in HFD-fed WT mice. On the
contrary, in TLR7/8ko mice the numbers and activation status
of splenic and hepatic Treg cells, as well as hepatic IL-10 levels
were normal. These results suggest that TLR7-expression by DCs
is pivotal in controlling Treg numbers and their activation status
in TLR8ko mice. Interestingly, increased percentages of splenic
Treg cells have also been reported in 8 and 16 weeks old female
BWF1 mice, which develop spontaneously SLE, hepatic steatosis,
and metabolic syndrome (57). However, in the same study it was
reported that by the age of 24 weeks the female BWF1 mice had
normal percentages of splenic Treg cells, a decline of metabolic
symptoms, while classical SLE symptoms increased progressively
(57). The observation that Treg cells did not decrease in 8
months old (34 weeks old) TLR8ko mice and even increased
upon HFD could be due to the fact that whole body homeostasis
deterioration is slower in TLR8ko mice than in BWF1 mice.
Indeed, a previous study using BWF1 female mice reported the
appearance of lupus-related signs earlier and a 69% survival
rate by week 36 (58), while in the study by Vila et al. survival
was 100% by week 36 (57). Therefore, the TLR7-dependent
increased numbers of Treg cells in TLR8ko mice might have a
reparatory role, since Treg cells besides their role in suppressing
the immune response are important in tissue protection and
regeneration in various tissues (59). Thus, we could hypothesize
that the numbers, activation status, heterogeneity, stability, and
function of Treg cells can vary during the different stages of SLE
progression (60). Furthermore, recent studies have uncovered
novel subsets of Treg cells that have a pathogenic role, notably
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through the secretion of the cytokine IL17A, in the setting of
the autoimmune diseases, including SLE and arthritis (61, 62),
which could also explain why the role of Treg cells in human
SLE remains contradictory. We this could not rule out that Treg
cells in HFD-fed TLR8ko mice contain pathogenic cells that
contribute to the pathology.
Obesity-related inflammation of metabolic tissues, including
liver and adipose tissue, are key elements in the development
of metabolic inflammation and insulin resistance, but many
of the contributing mechanisms remain ambiguous (63). Our
data revealed that in WT mice HFD leads to an increased
TLR7 expression that is coupled with increased TNF production
especially by splenic and hepatic cDCs and pDCs. Importantly,
increased TLR7 expression and signaling was even more
profound in TLR8ko mice and correlated with dramatic increase
of hepatic cytokines. In accordance with our findings that
HFD leads to increased TLR7 expression, a previous study
revealed that HFD upregulated the mRNA expression of all
TLRs, including TLR7, in the murine adipose tissue, and this
phenomenon was coupled by increased NF-κB signaling and
cytokine expression (64). Moreover, Revelo et al., showed that
HFD-induced obesity in male mice promotes excess release and
diminished clearance of nucleic acids, in the form of extracellular
traps, that can be detected by TLR7 and can lead to worsening of
metabolic inflammation (52). Interestingly, upregulated adipose
TLR7 expression and correlation with systemic inflammatory
markers has also been reported in obese individuals (65).
Thus, we can hypothesize that the increased TLR7 expression
and response that we noticed upon HFD mainly in DCs
could be the outcome of the activation of DCs either through
direct detection of the increased amounts of the endogenous
TLR7-ligand and/or increased inflammatory cytokines that lead
to DC activation. Increased TLR7 expression coupled with
increased TLR7 signaling has detrimental effects on accelerating
systemic metabolic inflammation and SLE progression. In
line to our findings, calorie restriction in mice delayed the
development of kidney disease, age-related immune dysfunction
and complications, and thus prolonged the life span in the BWF1
mousemodel of lupus (66–68). Information regarding the impact
of diet and caloric restriction on human SLE is yet insufficient
(2, 69). Nevertheless, caloric restriction was proven to induce
various benefits to the immune system (69), since this restriction
also leads to changes in the gutmicrobiota, which act as guardians
of a healthy immune system (70).
In conclusion, our data demonstrate that HFD-induced
obesity increases TLR7 expression and signaling, that contributes
to the acceleration of the progression of SLE and metabolic
abnormalities. Since SLE is a systemic inflammatory autoimmune
disease with a broad clinical and immunological phenotype,
whereas the observed clinical heterogeneity reflects differences
in underlying immunopathological process, treatment
personalization should be done according to underlying
molecular mechanisms (71). It is tempting to speculate that in
certain SLE patients the molecular basis of the disease could
be due to TLR7 overexpression and signaling, that if it is also
coupled with obesity and/or metabolic syndrome this could
have detrimental consequences for the initiation, exacerbation
and progression of the SLE pathology. Therefore, interventions
to reduce or reverse overweight and obesity could improve
both symptoms and long-term outcomes of patients with lupus
or systemic inflammation, and if this is not achievable then
targeting TLR7 is expected to have beneficial effects both for SLE
and for metabolic inflammation, especially in certain genetically
predisposed individuals.
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